Bedfordshire and Luton Joint Formulary Formulary

No results found when searching the local formulary, see alternative searches below.

Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.

Local	BNF	Section
Amivantamab	Amivantamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Atezolizumab	Atezolizumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Avelumab	Avelumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Belantamab	Belantamab Mafodotin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Bevacizumab	Bevacizumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Blinatumomab	Blinatumomab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Brentuximab	Brentuximab Vedotin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Cemiplimab	Cemiplimab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Cetuximab	Cetuximab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Daratumumab	Daratumumab	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Dinutuximab	Dinutuximab Beta [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Dostarlimab	Dostarlimab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Durvalumab	Durvalumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Elotuzumab	Elotuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Elranatamab	Elranatamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Enfortumab	Enfortumab Vedotin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Epcoritamab	Epcoritamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Gemtuzumab	Gemtuzumab Ozogamicin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Glofitamab	Glofitamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Inotuzumab	Inotuzumab Ozogamicin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Ipilimumab	Ipilimumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Isatuximab	Isatuximab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Loncastuximab	Loncastuximab Tesirine [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Mirvetuximab	Mirvetuximab Soravtansine [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Mogamulizumab	Mogamulizumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Mosunetuzumab	Mosunetuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Nivolumab	Nivolumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Nivolumab	Nivolumab With Relatlimab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Obinutuzumab	Obinutuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Panitumumab	Panitumumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Pembrolizumab	Pembrolizumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Pertuzumab	Pertuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Pertuzumab	Pertuzumab With Trastuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Polatuzumab	Polatuzumab Vedotin [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Ramucirumab	Ramucirumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Rituximab	Rituximab	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Sacituzumab	Sacituzumab Govitecan [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Siltuximab	Siltuximab	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Tafasitamab	Tafasitamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Talquetamab	Talquetamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Teclistamab	Teclistamab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Trastuzumab	Trastuzumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Trastuzumab	Trastuzumab Deruxtecan [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Trastuzumab	Trastuzumab Emtansine [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Tremelimumab	Tremelimumab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy
Zolbetuximab	Zolbetuximab [Specialist Drug]	Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies Antibody Responsive Malignancy

Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.

No exact matches found - Possible matches - use with care.

Status	Description	Section
	Antibacterials Stiemycin^®	Skin, Topical antibacterials for acne, 13.06.01
	Antibacterials Zindaclin^®	Skin, Topical antibacterials for acne, 13.06.01
	Antivenoms for non-indigenous venomous animals	Emergency Treatment of Poisoning, Poisoning, 18

This search uses logic to try to capture misspellings and may return results that were not expected.

Bedfordshire and Luton Joint Formulary

Bedfordshire Hospitals NHS Foundation TrustBedfordshire, Luton and Milton Keynes ICB

Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB